|
DE3064846D1
(en)
|
1979-12-19 |
1983-10-20 |
Duphar Int Res |
New nitrothiophenes, method of preparing the new compounds, as well as fungicidal and/or bactericidal compositions on the basis of the new compounds
|
|
US4456469A
(en)
|
1980-03-07 |
1984-06-26 |
E. I. Du Pont De Nemours And Company |
Pyridyl sulfone herbicides
|
|
AU543161B2
(en)
|
1980-03-07 |
1985-04-04 |
E.I. Du Pont De Nemours And Company |
Pyrimidine or s.triazine derivatives
|
|
US4791127A
(en)
|
1985-10-07 |
1988-12-13 |
Nippon Kayaku Kabushiki Kaisha |
Alkanesulfonate derivatives and their use as insecticides, acaricides or nematicides
|
|
DE3812177A1
(de)
|
1988-04-13 |
1989-10-26 |
Bayer Ag |
2-phenylsulfinyl-nitro-pyridine, verfahren zu ihrer herstellung und ihre verwendung
|
|
WO1995029897A1
(en)
|
1994-04-29 |
1995-11-09 |
G.D. Searle & Co. |
METHOD OF USING (H+/K+) ATPase INHIBITORS AS ANTIVIRAL AGENTS
|
|
WO1997008147A1
(de)
|
1995-08-24 |
1997-03-06 |
Basf Aktiengesellschaft |
N-heterocyclische verbindungen, zwischenprodukte für ihre herstellung, sie enthaltende mittel und ihre verwendung zur bekämpfung von schadpilzen
|
|
DE19531148A1
(de)
|
1995-08-24 |
1997-02-27 |
Basf Ag |
Fungizide Pyridin-2-yl-Derivate
|
|
WO1998054139A1
(de)
|
1997-05-30 |
1998-12-03 |
Basf Aktiengesellschaft |
Verfahren zur herstellung substituierter thiopyridine
|
|
US6284923B1
(en)
|
1997-08-22 |
2001-09-04 |
Tularik Inc |
Substituted benzene compounds as antiproliferative and cholesterol lowering action
|
|
AU9781098A
(en)
|
1997-10-02 |
1999-04-27 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
|
US6297239B1
(en)
|
1997-10-08 |
2001-10-02 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
|
US6191170B1
(en)
|
1998-01-13 |
2001-02-20 |
Tularik Inc. |
Benzenesulfonamides and benzamides as therapeutic agents
|
|
EP0930302B1
(en)
|
1998-01-16 |
2003-04-02 |
F.Hoffmann-La Roche Ag |
Benzosulfone derivatives
|
|
WO2001064642A2
(en)
|
2000-02-29 |
2001-09-07 |
Cor Therapeutics, Inc. |
Benzamides and related inhibitors of factor xa
|
|
US20030187026A1
(en)
|
2001-12-13 |
2003-10-02 |
Qun Li |
Kinase inhibitors
|
|
AU2003211427A1
(en)
|
2002-02-18 |
2003-09-04 |
Ishihara Sangyo Kaisha, Ltd. |
Pyridine derivatives or salts thereof and cytokine production inhibitors containing the same
|
|
US20030236287A1
(en)
|
2002-05-03 |
2003-12-25 |
Piotrowski David W. |
Positive allosteric modulators of the nicotinic acetylcholine receptor
|
|
US7037902B2
(en)
*
|
2002-07-03 |
2006-05-02 |
Receptron, Inc. |
Affinity small molecules for the EPO receptor
|
|
EP1651595A2
(en)
|
2003-05-30 |
2006-05-03 |
Rigel Pharmaceuticals, Inc. |
Ubiquitin ligase inhibitors
|
|
PL1756084T3
(pl)
|
2004-06-04 |
2009-06-30 |
Arena Pharm Inc |
Podstawione pochodne arylowe i heteroarylowe jako modulatory metabolizmu oraz profilaktyka i leczenie zaburzeń z metabolizmem związanych
|
|
US20060019967A1
(en)
*
|
2004-07-21 |
2006-01-26 |
Su-Ying Wu |
SARS CoV main protease inhibitors
|
|
GB0426313D0
(en)
|
2004-12-01 |
2005-01-05 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
WO2006083692A2
(en)
|
2005-01-28 |
2006-08-10 |
Mount Sinai Schoool Of Medicine |
Methods of identifying modulators of bromodomains
|
|
GB0504828D0
(en)
|
2005-03-09 |
2005-04-13 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
EP1976495A2
(en)
|
2006-01-06 |
2008-10-08 |
Aarhus Universitet |
Compounds acting on the serotonin transporter
|
|
CA2647338A1
(en)
|
2006-04-28 |
2007-11-08 |
Avexa Limited |
Integrase inhibitors-3
|
|
US20090005422A1
(en)
*
|
2006-05-22 |
2009-01-01 |
Thioredoxin Systems Ab |
Bacterial thioredoxin reductase inhibitors and methods for use thereof
|
|
WO2009012283A1
(en)
|
2007-07-17 |
2009-01-22 |
Plexxikon Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
|
CN101723932B
(zh)
|
2008-10-31 |
2013-11-20 |
北京以岭生物工程技术有限公司 |
硝基吡啶乙烯亚胺化合物、其药物组合物及其制备方法和用途
|
|
CA2763589A1
(en)
*
|
2009-05-28 |
2010-12-02 |
President And Fellows Of Harvard College |
N,n'-diarylurea compounds and n,n'-diarylthiourea compounds as inhibitors of translation initiation
|
|
NZ713361A
(en)
|
2009-08-17 |
2017-06-30 |
Memorial Sloan Kettering Cancer Center |
Heat shock protein binding compounds, compositions, and methods for making and using same
|
|
WO2011099502A1
(ja)
|
2010-02-10 |
2011-08-18 |
公立大学法人横浜市立大学 |
神経選択的転写抑制因子NRSFに特異的に結合するmSin3B に結合する化合物の利用
|
|
CN102206172B
(zh)
|
2010-03-30 |
2015-02-25 |
中国医学科学院医药生物技术研究所 |
一组取代双芳基化合物及其制备方法和抗病毒应用
|
|
EP2609089A1
(en)
|
2010-08-27 |
2013-07-03 |
Universität des Saarlandes |
Selective 17beta-hydroxysteroid dehydrogenase type 1 inhibitors
|
|
CN104220053B
(zh)
|
2012-02-10 |
2017-05-03 |
德克萨斯大学系统董事会 |
cAMP直接活化交换蛋白(EPAC)的调节剂
|
|
JP6393322B2
(ja)
|
2013-07-10 |
2018-09-19 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新規なキラル窒素−リン配位子及びアルケン類の不斉水素化のためのその使用
|
|
CN104672214B
(zh)
|
2013-12-03 |
2019-04-12 |
上海翰森生物医药科技有限公司 |
具有alk抑制活性的化合物及其制备与用途
|
|
CN105503827B
(zh)
|
2014-10-11 |
2019-09-24 |
上海翰森生物医药科技有限公司 |
Egfr抑制剂及其制备方法和用途
|
|
CN105085483B
(zh)
|
2015-06-04 |
2019-01-01 |
湖北生物医药产业技术研究院有限公司 |
激酶抑制剂及其应用
|
|
CN104987324B
(zh)
|
2015-06-04 |
2018-05-04 |
湖北生物医药产业技术研究院有限公司 |
作为alk抑制剂的嘧啶衍生物
|
|
GB201514021D0
(en)
|
2015-08-07 |
2015-09-23 |
Arner Elias Set Jeno |
Novel Pyridines and their use in the treatment of cancer
|
|
MA47450A
(fr)
*
|
2017-02-07 |
2019-12-18 |
Oblique Therapeutics Ab |
Sulfinylpyridines et leur utilisation dans le traitement du cancer
|
|
AU2018218521C1
(en)
|
2017-02-07 |
2022-06-09 |
Oblique Therapeutics Ab |
Heterocyclylsulfonyl-substituted pyridines and their use in the treatment of cancer
|
|
CA3051539A1
(en)
|
2017-02-07 |
2018-08-16 |
Oblique Therapeutics Ab |
Hydrocarbylsulfonyl-substituted pyridines and their use in the treatment of cancer
|
|
JP2020507625A
(ja)
|
2017-02-07 |
2020-03-12 |
オブリーク セラピューティクス アーベー |
ヘテロアリールスルホニル置換ピリジンおよび癌の治療におけるそれらの使用
|